Also trades as: MEDANTA.BO (BSE) · $vol 1M · GLH.AX (ASX) · $vol 0M
MEDANTA.NS NSE
Global Health Limited
1W: -9.9%
1M: -6.9%
3M: +0.5%
YTD: +19.1%
1Y: +0.2%
3Y: +103.7%
₹1,357.00 ($14.10)
-8.00 (-0.59%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$59.1B
+23.9% ▲
5Y CAGR: +17.0%
Total Liabilities
$19.2B
+39.3% ▲
5Y CAGR: +7.9%
Shareholders Equity
$39.6B
+17.0% ▲
5Y CAGR: +23.4%
Cash & Investments
$11.3B
+7.6% ▲
5Y CAGR: +31.3%
Total Debt
$11.9B
+65.8% ▲
5Y CAGR: +5.0%
Net Debt
$10.6B
+362.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.2B | $7.7B | $4.2B | $2.3B | $1.3B |
| Short-Term Investments | $3.9B | $4.9B | $7.3B | $8.2B | $10.0B |
| Cash & ST Investments | $5.1B | $12.6B | $11.6B | $10.5B | $11.3B |
| Net Receivables | $2.2B | $2.2B | $2.4B | $2.9B | $4.1B |
| Inventory | $555M | $604M | $668M | $671M | $790M |
| Other Current Assets | $125M | $258M | $419M | $1.2B | $545M |
| Total Current Assets | $8.1B | $15.8B | $15.1B | $15.3B | $16.7B |
| Property, Plant & Equip. | $22.1B | $23.7B | $26.2B | $30.4B | $39.1B |
| Goodwill & Intangibles | $63M | $52M | $55M | $113M | $162M |
| Long-Term Investments | -$3.8B | -$4.5B | $104M | $182M | $941M |
| Other Non-Current Assets | $4.7B | $1.3B | $1.0B | $1.7B | $1.9B |
| Total Non-Current Assets | $23.3B | $25.4B | $28.0B | $32.3B | $42.3B |
| Total Assets | $31.5B | $41.2B | $43.0B | $47.7B | $59.1B |
| — Liabilities — | |||||
| Accounts Payable | $1.3B | $602M | $1.9B | $1.9B | $2.4B |
| Short-Term Debt | $702M | $1.1B | $1.4B | $638M | $300M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $674M | $2.4B | $1.4B | $3.3B | $3.2B |
| Total Current Liabilities | $4.2B | $5.7B | $6.2B | $6.2B | $6.3B |
| Long-Term Debt | $7.7B | $7.4B | $2.8B | $2.6B | $6.0B |
| Other Non-Current Liab. | $848M | $900M | $977M | $1.1B | $1.7B |
| Total Non-Current Liabilities | $11.1B | $11.2B | $7.8B | $7.6B | $12.9B |
| Total Liabilities | $15.3B | $16.9B | $14.0B | $13.8B | $19.2B |
| — Equity — | |||||
| Common Stock | $506M | $536M | $537M | $537M | $537M |
| Retained Earnings | $9.5B | $12.8B | $17.6B | $22.5B | $28.0B |
| Accumulated OCI | $274M | $237M | $196M | $122M | $283M |
| Total Stockholders Equity | $16.2B | $24.3B | $29.1B | $33.9B | $39.6B |
| Total Liabilities & Equity | $31.5B | $41.2B | $43.0B | $47.7B | $59.1B |
| — Key Metrics — | |||||
| Total Debt | $11.1B | $11.2B | $8.0B | $7.2B | $11.9B |
| Net Debt | $9.9B | $3.5B | $3.8B | -$4.0B | $10.6B |
| Total Investments | $105M | $430M | $7.4B | $8.4B | $11.0B |